SILEXION THERAPEUTICS CORP
Q4 2025 13F Holders
Symbol
SLXN
CUSIP
G1281K130
Type
Equity
Class
ORD SHS NEW
Num filers
6
Total reported value, excl. options
$35.2 k
Compare 2025 Q4 to
2026 Q1
2025 Q3
2025 Q2
Manager
Report Date
Value ($000)
Shares
Option Type